🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/05/1993 | 18,01 | 18,01 | 17,47 | 17,53 | -2,33% | 2,98% | 4.023.482 |
| 11/05/1993 | 18,07 | 18,13 | 17,77 | 17,95 | -0,33% | 1,98% | 3.378.962 |
| 10/05/1993 | 17,89 | 18,19 | 17,83 | 18,01 | +1,68% | 2,00% | 4.297.010 |
| 07/05/1993 | 17,95 | 18,01 | 17,71 | 17,71 | -1,00% | 1,66% | 2.598.202 |
| 06/05/1993 | 18,13 | 18,19 | 17,77 | 17,89 | -1,96% | 2,30% | 4.593.594 |
| 05/05/1993 | 18,25 | 18,55 | 18,19 | 18,25 | -0,33% | 1,96% | 6.014.053 |
| 04/05/1993 | 18,31 | 18,61 | 18,13 | 18,31 | +0,33% | 2,61% | 6.697.139 |
| 03/05/1993 | 17,77 | 18,25 | 17,71 | 18,25 | +3,38% | 3,02% | 7.402.234 |
| 30/04/1993 | 17,71 | 18,01 | 17,59 | 17,65 | +0,00% | 2,36% | 4.970.245 |
| 29/04/1993 | 17,83 | 17,83 | 17,47 | 17,65 | -1,00% | 2,01% | 2.891.013 |
| 28/04/1993 | 17,89 | 17,95 | 17,59 | 17,83 | +0,67% | 2,00% | 7.006.509 |
| 27/04/1993 | 17,24 | 17,89 | 17,24 | 17,71 | +2,77% | 3,81% | 9.263.901 |
| 26/04/1993 | 17,00 | 17,35 | 16,94 | 17,24 | +0,35% | 2,46% | 4.473.493 |
| 23/04/1993 | 16,76 | 17,18 | 16,76 | 17,18 | +2,49% | 2,49% | 4.221.973 |
| 22/04/1993 | 17,53 | 17,53 | 16,64 | 16,76 | -4,42% | 5,10% | 5.922.667 |
| 21/04/1993 | 17,89 | 17,89 | 17,47 | 17,53 | -2,00% | 2,33% | 5.588.355 |
| 20/04/1993 | 17,35 | 17,89 | 17,24 | 17,89 | +4,53% | 3,78% | 10.699.661 |
| 19/04/1993 | 16,22 | 17,18 | 16,22 | 17,12 | +5,51% | 5,88% | 6.634.469 |
| 16/04/1993 | 15,86 | 16,22 | 15,74 | 16,22 | +2,64% | 3,01% | 7.692.320 |
| 15/04/1993 | 16,10 | 16,16 | 15,74 | 15,80 | -1,85% | 2,59% | 6.165.803 |
| 14/04/1993 | 16,22 | 16,28 | 16,04 | 16,10 | -0,37% | 1,47% | 4.122.832 |
| 13/04/1993 | 16,40 | 16,58 | 16,04 | 16,16 | -1,09% | 3,27% | 5.888.502 |
| 12/04/1993 | 15,86 | 16,46 | 15,80 | 16,34 | +3,40% | 4,14% | 6.136.878 |
| 08/04/1993 | 16,22 | 16,22 | 15,74 | 15,80 | -2,21% | 2,94% | 6.203.950 |
| 07/04/1993 | 16,10 | 16,34 | 16,04 | 16,16 | +0,00% | 1,85% | 5.065.403 |
| 06/04/1993 | 16,22 | 16,34 | 16,04 | 16,16 | -0,73% | 1,84% | 5.239.371 |
| 05/04/1993 | 16,52 | 16,52 | 16,10 | 16,28 | +0,37% | 2,53% | 6.395.734 |
| 02/04/1993 | 16,34 | 16,40 | 16,10 | 16,22 | -1,09% | 1,82% | 8.983.456 |
| 01/04/1993 | 16,76 | 16,82 | 16,40 | 16,40 | -2,83% | 2,49% | 8.121.581 |
| 31/03/1993 | 17,41 | 17,65 | 16,70 | 16,88 | -1,39% | 5,48% | 11.701.968 |